Specify a stock or a cryptocurrency in the search bar to get a summary
Panacos Pharmaceuticals Inc
PANCPanacos Pharmaceuticals, Inc., a development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The company's discovery technologies focus on novel targets in the virus life cycle, including virus maturation and virus fusion. Its product pipeline includes second- and third-generation programs in HIV maturation inhibition. The company was founded in 1999 and is headquartered in Watertown, Massachusetts. Address: 134 Coolidge Avenue, Watertown, MA, United States, 02472
Analytics
WallStreet Target Price
3 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures PANC
Dividend Analytics PANC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PANC
Stock Valuation PANC
Financials PANC
Results | 2019 | Dynamics |